1. At a Glance
Gandhar Oil is India’s heavyweight in white oils—a niche but critical product used across consumer goods, healthcare, lubricants, and pharmaceuticals. With a solid 26.5% domestic market share and nearly 10% global share, Gandhar punches above its ₹1,562 crore market cap. The stock trades at a reasonable 19.5 P/E with a modest dividend yield of 0.31%. ROCE sits at 10.6%, ROE at a subdued 6.65%. Sales growth has slowed to under 10% over five years, and margins are under pressure. The share price has fallen from ₹253 highs to ₹160, reflecting market worries on profit sustainability. Time to see if this oil giant is slipping or gearing up for another surge.
2. Introduction
Incorporated in 1992, Gandhar Oil is a powerhouse in white oils—clear, refined mineral oils widely used as bases in pharmaceuticals, cosmetics, and food industries. Being one of the top 5 global players, Gandhar controls more than a quarter of India’s market and a respectable chunk worldwide.
The company’s journey has been about steady market share gains and volume growth, riding demand from end-user industries that rely on high-purity mineral oils. However, the last few years show challenges: margin pressure, volatility in raw material costs, and tepid sales growth. With competitors like Castrol India and Gulf Oil Lubricants having much larger scale and better profitability, Gandhar must innovate or risk being squeezed.
3. Business Model (WTF Do They Even Do?)
Gandhar manufactures and sells white oils—ultra-pure mineral oils—along with specialty petroleum products for industrial and consumer applications. These oils serve as raw materials for cosmetics, pharmaceuticals, lubricants, and other downstream industries.
The company operates refining and blending units, sourcing crude and semi-processed feedstock to manufacture white oils meeting stringent quality standards. It leverages long-term relationships and regulatory certifications to supply Indian and international customers. Their business depends heavily on scale, quality, and ability to manage fluctuating crude oil prices.
4. Financials Overview
For FY25, Gandhar reported revenues of ₹3,897 crore, a slight dip from previous years reflecting weak demand or pricing challenges. Operating profit dropped sharply to ₹176 crore (5% margin), down from ₹317 crore at FY23 peak. Net profit slid to ₹83 crore, less than half of FY23’s ₹214 crore. EPS stands at ₹8.18 on a share price of ₹160, translating to a P/E of ~19.5—reasonable, but pricing in a lot of uncertainty.
ROCE and ROE have eroded to 10.6% and 6.65%, a red flag for capital efficiency and shareholder returns. Dividend payout is meager, just 3.9% of profits, frustrating income investors.
The company faces raw material volatility and competitive pressures. Interest costs remain high (~₹49 crore FY25), eating into profits. Inventory days and working capital cycle are stretched (50 and 76 days respectively), tying up cash.
5. Valuation
Valuation Range Estimate Using Three Methods:
- P/E Method: EPS ₹8.18; typical P/E for specialty chemical/refining firms 15–20x → Fair value ₹123–₹164 (Current ₹160 near upper band)
- EV/EBITDA Method: EBITDA ~₹176 crore; EV = Market Cap ₹1,562 Cr + Debt ₹305 Cr ≈ ₹1,867 Cr; EV/EBITDA ≈ 10.6x. Sector average EV/EBITDA ~8–12x → Fair EV ₹1408–2112 Cr → Price range ₹110–₹165
- DCF (simplified): Assuming 5% growth, 10% discount, 3% terminal growth, margin steady at 5% → Fair value ₹140–₹160
Summary: Stock currently fairly valued, possibly slightly expensive if margin pressures continue.
6. What’s Cooking – News, Triggers, Drama
- July 2025: CSR initiatives like dialysis center inauguration by Gandhar Foundation highlight brand goodwill.
- August 2025: Board meeting scheduled to approve Q1 FY26 results — watch for
